Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 AUD | -4.35% | -8.33% | -18.52% |
Apr. 19 | Genetic Technologies Raising $2 Million via ADS Offering | MT |
Apr. 18 | Top Midday Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-18.52% | 9.97M | |
-14.37% | 85.02B | |
+13.99% | 82.37B | |
+9.37% | 29.29B | |
-10.28% | 17.21B | |
-0.36% | 16.7B | |
+0.79% | 15.5B | |
+4.32% | 12.15B | |
-2.34% | 12.13B | |
+32.14% | 12.12B |
- Stock Market
- Equities
- GTG Stock
- News Genetic Technologies Limited
- Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer